News

Seasonal message from the EU-CardioRNA COST Action

December 21, 2020

Dear EU-CardioRNA colleague,   As the calendar year approaches its end, we want to firstly wish you all a very safe and hopefully enjoyable festive season.   Whilst this year has brought much unrest, stress and sadness to some, we hope you are feeling optimistic towards 2021, especially with the news of vaccination schemes commencing. […]

Hot off the press! New article on using miRNA prediction of cardiovascular events in IJMS

December 20, 2020

New article in the EU-CardioRNA IJMS Special Issue from Teodora Barbalata, Yvan Devaux, Loredan Stefan Niculescu and colleagues on circulating and plaque miRNA levels as a predictive measure of cardiovascular events.

Vacancy for a Research Fellow, Centre for Cardiovascular Science, University of Edinburgh

December 4, 2020

A fantastic open position is now available for a Research Fellow to contribute to the management and publishing of work funded by Professor Baker’s British Heart Foundation Programme Grant to the role of non-coding RNA in cardiovascular disease. The successful candidate will be involved with analysis of both single cell data, microRNA and long non-coding […]

UK Medical Research Council grant awarded to EU CardioRNA member Katja Gehmlich, University of Birmingham

December 3, 2020

Medical Research Council award: Targeted therapies for heart failure research receives £850,000 boost Dr Katja Gehmlich, Senior Lecturer at the Institute of Cardiovascular Sciences, University of  Birmingham, and Justin Benesch, Professor of Biophysical Chemistry, University of Oxford, have been jointly awarded a three-year research grant from the Medical Research Council to understand how cardiac mechano-sensing works to help […]

TACKLING COVID-19: THE NEW EU-FUNDED COVIRNA PROJECT HAS KICKED OFF!

December 3, 2020

TACKLING COVID-19: THE NEW EU-FUNDED COVIRNA PROJECT A diagnostic test to improve surveillance and care of COVID-19 patients  The COVIRNA project, led by the Luxembourg Institute of Health (LIH), is  one of the 23 research projects awarded within the framework of the Horizon 2020 call for Expression of Interest  “Innovative and rapid health-related approaches to […]

TargetID – new program lead by our EU-CardioRNA colleagues at the University of Malta

December 3, 2020

TargetID will identify genes that regulate molecules that show deranged expression after SARS-Cov-2 infection, with the aim of finding suitable drug targets that will prevent COVID-19 induced cytokine storms. RNA-Seq and whole genome sequencing data will be generated from 1000 individuals and analysed using a combination of approaches. This project will lead to a number […]

New WG2 Leadership team: Best practices and experimental standards

November 16, 2020

We are pleased to confirm the new leadership of CardioRNA Working Group 2 as follows: –          Louise Torp Dalgard, WG2 leader (DK) –          Paivi Lakkisto, WG2 co-leader (FI) –          David de Gonzalo Calvo, WG2 ECI co-leader (SP). A warm welcome to WG2 leaders! See here for more information on CardioRNA WG2:

LIH News: EU-CardioRNA COST Action

October 31, 2020

With our EU-CardioRNA Chair, project manager as well as numerous member based at the Luxembourg Institute of Health (LIH), LIH is proud of the contribution our network plays in large scale international collaboration in translational research.

EHJ Cardiopulse article ‘Transcriptomics Research to Improve Cardiovascular Healthcare’

October 15, 2020

An important overview of how transcriptomics research can improve cardiovascular healthcare written by our very own Yvan Devaux and Lina Badimon is out now in the European Heart Journal!  

Launch of EU-CardioRNA book ‘Epigenetics in Cardiovascular Disease’

October 15, 2020

We are delighted to announce the launch of a new book: Epigenetics in Cardiovascular Disease, part of the Elsevier book series in Translational Epigenetics, expected to be released 1st March 2021.   Twenty-one illustrated chapters prepared by members of the EU-CardioRNA COST Action present the role of epigenetic mechanisms in cardiovascular disease, focusing on key […]

GROUP LEADER OPPORTUNITIES AT THE MRC HUMAN GENETICS UNIT, UNIVERSITY OF EDINBURGH

October 8, 2020

The MRC Human Genetics Unit at the University of Edinburgh, UK are seeking to recruit new group leaders at tenure or tenure track level The MRC HGU – the UK’s largest MRC Unit – combines the latest computational and experimental technologies to investigate how our genomes work to control the function of molecules, cells and […]

EU-CardioRNA – Two years already!

October 8, 2020

Dear colleagues, dear friends,   On October 4th, 2018 we had the kick-off meeting of our CardioRNA COST Action in the COST premises in Brussels. Since then the network has continuously grown and accounts now more than 170 participants. Two years already, and a lot of science, exchange and fun. On behalf of CardioRNA COST […]

1 2 3 … 8